Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
- 11 July 1998
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 61 (8), 1053-1071
- https://doi.org/10.1021/np9800102
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine ReceptorsScience, 1998
- Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistanceTrends in Microbiology, 1997
- Galanthamine in Alzheimer??s DiseaseCNS Drugs, 1997
- Clinical Pharmacology and Therapeutic Potential of Artemisinin and its Derivatives in the Treatment of MalariaDrugs, 1996
- Comparative Review of Dopamine Receptor Agonists in Parkinsonʼs DiseaseCNS Drugs, 1996
- Forskolin Derivatives. I. Synthesis, and Cardiovascular and Adenylate Cyclase-Stimulating Activities of Water-Soluble Forskolins.CHEMICAL & PHARMACEUTICAL BULLETIN, 1996
- Overexpression of the NC4 domain of type IX collagen induces osteoarthritis in miceInflammation Research, 1995
- Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trialCritical Care Medicine, 1994
- Chemie und Biochemie mikrobieller α‐Glucosidasen‐InhibitorenAngewandte Chemie, 1981
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976